Imaging is today crucial for patient management not only thanks to its high sensibility to detect uterine carcinoma (endovaginal ultrasonography for endometrial carcinoma) but also for local staging using pelvic MR imaging (until 2009 recommended by FIGO for both endometrial and cervical carcinoma) and for the evaluation of treatment response under radiochemotherapy especially for cervical carcinoma (using MR imaging and PET-CT).